EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS060-09025 
Organism
Homo sapiens 
Tissue/cell
GM12891 
Coordinate
chr12:133020840-133022970 
TF binding sites/motifs
Number: 27             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
ATF3MA0605.2chr12:133022695-133022707GATGACGTCACC+6.74
ATF3MA0605.2chr12:133022796-133022808GATGACGTCACC+6.74
ATF3MA0605.2chr12:133022847-133022859GATGACGTCACC+6.74
ATF3MA0605.2chr12:133022897-133022909GATGACGTCACC+6.74
ATF3MA0605.2chr12:133022695-133022707GATGACGTCACC-6.92
ATF3MA0605.2chr12:133022796-133022808GATGACGTCACC-6.92
ATF3MA0605.2chr12:133022847-133022859GATGACGTCACC-6.92
ATF3MA0605.2chr12:133022897-133022909GATGACGTCACC-6.92
CREB1MA0018.3chr12:133022644-133022656TATGACGTCACC+6.02
CREB1MA0018.3chr12:133022745-133022757TATGACGTCACC+6.02
CREB1MA0018.3chr12:133022644-133022656TATGACGTCACC-6.02
CREB1MA0018.3chr12:133022745-133022757TATGACGTCACC-6.02
CREB1MA0018.3chr12:133022695-133022707GATGACGTCACC+6.74
CREB1MA0018.3chr12:133022796-133022808GATGACGTCACC+6.74
CREB1MA0018.3chr12:133022847-133022859GATGACGTCACC+6.74
CREB1MA0018.3chr12:133022897-133022909GATGACGTCACC+6.74
CREB1MA0018.3chr12:133022695-133022707GATGACGTCACC-6.74
CREB1MA0018.3chr12:133022796-133022808GATGACGTCACC-6.74
CREB1MA0018.3chr12:133022847-133022859GATGACGTCACC-6.74
CREB1MA0018.3chr12:133022897-133022909GATGACGTCACC-6.74
JDP2(var.2)MA0656.1chr12:133022644-133022656TATGACGTCACC+6.14
JDP2(var.2)MA0656.1chr12:133022745-133022757TATGACGTCACC+6.14
JDP2(var.2)MA0656.1chr12:133022695-133022707GATGACGTCACC+6.92
JDP2(var.2)MA0656.1chr12:133022796-133022808GATGACGTCACC+6.92
JDP2(var.2)MA0656.1chr12:133022847-133022859GATGACGTCACC+6.92
JDP2(var.2)MA0656.1chr12:133022897-133022909GATGACGTCACC+6.92
PRDM1MA0508.2chr12:133021450-133021460TCACTTTCAC+6.02
Number of super-enhancer constituents: 1             
IDCoordinateTissue/cell
SE_10775chr12:133020028-133023469CD19_Primary
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 3             
ChromosomeStartEnd
chr12133021598133021727
chr12133021781133022391
chr12133021534133022956
Number: 1             
IDChromosomeStartEnd
GH12I132443chr12133020139133023744
Enhancer Sequence
TCCCTCTTTG GGGAGCAAGA CCCTTGTGAG ATGCCACCGC CACCCTCGGG AGGCCTCCAG 60
GCTGGGGGAC GGGCACTGTG GGCTGCTGGT GTAGGGCCGG ACGCTCTCTG ACAGTGTTGC 120
CCCTGGCCTC CGGCGGCTTC CTCCCAAGCT GGGTTGGGGC TCTTCTGAAC GCTCCCCTCC 180
ATGCCCTGTC CTGGGAACTT TAACCCTCTG GGCCTCCCGG AGCCCTCTGT CTCCCCTGTC 240
CCAGGGGGTC TGCTGGGCTC CACCGGGCCC CGCCCTGAAT GCAGCCTGGA GCAACGCTGG 300
AGGCCGGGGC TAGGAAACTG TGAGCCCCGC CTTGTCTGTG TCTTTCTCAG GGATTCTCGT 360
CCTTTCCAAC CTGGTGCCCG ATGTCCGGAA GCACCTCTTC TGTGTTTTCA AATGGGAGAG 420
CGAATCCAGT CCTTTTCACT CCATTTTGGC CAGAAACAGA AGTCCTCCGT GATTTATATT 480
TTTACTAGAA TCTTTTAAAG GGGCACAAAT GGGGGTGTTT TGCAGGCATA CAGAAGCCCC 540
CGTCACTCCT CCCGCCTTGT CTCTGAACCG CTGTGGGGTG GGGAGGGGTC TCTTCTCTCT 600
CCAACCCACA TCACTTTCAC CCCCCGCCGG CCAAGGCTGC GTTTCCCTCG CCCCCACCCC 660
AGTCCCCCGC GTTGGTAGTG GGATCGGTTT GGTATTCTGA GGCTTCTCTC ATTTCTCCTT 720
TATCACCATC TGCCCCACAG CAGGCAGGCC CGGAGCCTCT GCAGAAGGGG GAACCGGGTG 780
CAGGCCCAAC GCCGGTCTCT CAGTGTGGCA GCCTTGCGCG CGAGCAGAAG CAGAAGGCCT 840
AGTTCCTACT CTGCAGCCTT GGCTGCCGGG CACGGAGAAC GTTTTAGCAG AAACACCTCT 900
GCAAAACCAC TTCCTGGCCC GGGCCCAGCC AAACACCATC TTCTCCTCCA CCCCAGGGCT 960
CCGCCCCCAT CTCCAGGCTC AGCCCAGCAC CCCCACCCCC GAAACCCCCA GCCCCACTGC 1020
ATCTGCCCTG GCCATCTGCC TCCGCCCTGC CTCGCTAACA CAGTTATTAA TGAGCAATTT 1080
TCCTGTAATT ACAACGCAGT TATGCCAGTT ACCCCGACCT GCTGACAGAG AGCATTCACT 1140
TCCATGTGGC ACTAGCCCCC AGGCCTGAGA GGACGCAAAC ACTTGCCCCT CATTCGCTGC 1200
CCCCACCCCC ACTCTGCCAG CCAGCACCAC CCTCCACCCA CTCTAGGCCC TTAAGAAAGG 1260
AGGGAAGGGC CGCGGGGAGG AGCTCTCAGA TCCCGAGGCC CCACTCCCCC TGCAAGGAAG 1320
GCTGTGAGCT CGGCCCCAGC CCACCTGCCA GCTCCCCAAA CACCTCCCAC CTCCCTCCGC 1380
CGCCTCCTGA AGGGACTACA CTCCCCTGGC TCCTCCAAAA TCCGCTAATG AACAGCAGGC 1440
GCAGAGGCTC CGCCACCGGC GTGCTCCTGG CCTCAGCCCT CCCTGTTCTG AAACCGCCTT 1500
TGCTAAGACG GTAGTAGTGA GGAATCACGA CAGTGGCAGA GGCCAACCTG ACCCGCTCCA 1560
CCTGCCTCCA CCCCAACCCG CCCGGCTGCT TCCTGAGCGT GGGCCAAACT AACTTTGACA 1620
GGAACTTAGT TTACAGTTTA AGTTGGGAAC AAAAAGGATA ACAGCCCCTC CCCAAAACAG 1680
ATTCCCTCCT CGCTTGGGGG GACCAGTCCC GTTGTAAAAC CGACAAATAA CAGCAGGATT 1740
AGGAATTCCG GCTCAGGATT CACGCAGCCA GACGCCACAG GACTCCTCCC CAGCCGCTCC 1800
TGTATATGAC GTCACCGCCG TAAGACCACA GGACACCGCC CCAGCCGCGC CTGTAGATGA 1860
CGTCACCATC GTAAGACCAC AGGACCCTTC CCAGCCGCTC CTGTATATGA CGTCACCGCC 1920
GTAAGACCAC AAGTCACCGC CCCAGCCGCT CCTGTAGATG ACGTCACCAC AGTAAGACCA 1980
CAGGATACCG CCCCAGCCGC GCCTGTAGAT GACGTCACCA TCGTAGGCCC ACAGGACCCT 2040
TCCCAGCCGC TCCTGTGGAT GACGTCACCG CCGTAGGACC TAAGATTGAT GCTGGAGAGG 2100
TTCTTCAGAC CCTGCGTTCT GACGGCTCCG 2130